- 暂无数据
简体中文
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Researchers from Materials Science at Harbin Institute of Technology, Zhengzhou Research Institute at Harbin Institute of Technology, and Key Laboratory of Microsystems and Microstructure Manufacturing at Harbin Institute of Technology, Ministry of Education, reviewed and reported on the research progress of laser surface cleaning of carbon fiber reinforced polymer composites (CFRP). The relevant ...
The use of photons to directly or indirectly drive chemical reactions has fundamentally changed the field of nanomaterial synthesis, leading to the emergence of new sustainable laser chemistry methods for manufacturing micro - and nanostructures. The incident laser radiation triggers complex interactions between chemical and physical processes at the interface between solid surfaces and liquid or ...
Researchers at the University of California, Santa Barbara have made significant breakthroughs in laser technology, introducing a groundbreaking quantum dot mode-locked laser that allows for independent generation of amplitude and frequency modulation combs from a single device. This cutting-edge dual mode laser paves the way for the creation of small-sized and energy-efficient frequency combs for...
Streamlight, a leading supplier of high-performance lighting and weapon lights/laser aiming equipment, has launched upgraded models of its TLR RM 1 and TLR RM 2 series of lights, each now equipped with an HPL face cap, providing ultra bright beams of up to 1000 lumens and an extended range of up to 22000 candela.The popular TLR RM 1 and TLR RM 2 models are equipped with red or green lasers, both o...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...